Besides, when BMSCs were transplanted in mice with experimental inflammatory bowel disease (IBD) or experimental autoimmune encephalomyelitis (EAE), the therapeutic efficacy of BMSCs was significantly decreased after Nap1l2 overexpression. The gene discussed is NAP1L2; the disease is experimental autoimmune encephalomyelitis.